FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2396425352> ?p ?o ?g. }

• W2396425352 endingPage "473" @default.
• W2396425352 startingPage "457" @default.
• W2396425352 abstract "An oral polybacterial immunomodulator Urostim (U), composed of killed cells and their lysates from E. coli expressing type 1 and Pili, E. coli Rc mutant, P. mirabilis, K. pneumoniae and E. faecalis was created for immunoprophylaxis and immunotherapy of urinary tract infections (UTIs). In experimental animal models, the stimulating effect of U on lymphocyte functional activity, macrophage phagocytosis and antibody producing cells, was established. In this study the immuno-modulating effects of U on the proliferating capacity and ultrastructural morphologic changes of lymphocytes, cytokine production and specific systemic humoral and mucosal immune responses in patients with UTIs have been evaluated. Patients enrolled in the study, received orally 50 mg U daily for a period of three months. On days 0, 30 and 90 a quantitative analysis was performed on lymphoproliferative responses to polyclonal mitogens, IL-2 and the specific antigen U, the production of specific serum and saliva IgA, IgM and IgG antibodies to all components of U and the concentration of pro-inflammatory cytokines. There was significant improvement of non-specific and specific lymphoproliferative responses on days 30 and 90 after the onset of treatment with U, confirmed by electronmicroscopic studies. The highest concentrations of serum proinflammatory cytokines TNF-alpha, IL-1beta and IL-6 were registered at baseline followed by a decrease until the end of the observation period. This finding correlates with the gradual decrease of immune activation as measured by the spontaneous lymphocyte proliferation. Data from the production of specific antibacterial antibodies in serum and saliva show two types of reactions. The first type was registered in patients with low pre-treatment levels in whom the concentration of specific antibodies increased on days 30 and 90. The second type of reaction was observed in patients with high pre-treatment levels, which dropped on day 30 and were usually followed by an increase at the end of the study. These results provide evidence for the immuno-modulating effect of U. Our data show that the oral administration of the polybacterial immunomodulator Urostim stimulates adequate cellular and humoral systemic and mucosal immune responses in patients with chronic UTIs." @default.
• W2396425352 created "2016-06-24" @default.
• W2396425352 creator A5000552772 @default.
• W2396425352 creator A5022630980 @default.
• W2396425352 creator A5032110612 @default.
• W2396425352 creator A5035811881 @default.
• W2396425352 creator A5051822232 @default.
• W2396425352 creator A5062084163 @default.
• W2396425352 creator A5077131670 @default.
• W2396425352 date "2005-07-01" @default.
• W2396425352 modified "2023-10-17" @default.
• W2396425352 title "Cellular and Humoral Systemic and Mucosal Immune Responses Stimulated by an Oral Polybacterial Immunomodulator in Patients with Chronic Urinary Tract Infections" @default.
• W2396425352 cites W1775935628 @default.
• W2396425352 cites W1866086464 @default.
• W2396425352 cites W1871555078 @default.
• W2396425352 cites W1932254683 @default.
• W2396425352 cites W1955931243 @default.
• W2396425352 cites W1972436424 @default.
• W2396425352 cites W1974001909 @default.
• W2396425352 cites W1981183339 @default.
• W2396425352 cites W1981333885 @default.
• W2396425352 cites W1988638383 @default.
• W2396425352 cites W1989204224 @default.
• W2396425352 cites W2002165341 @default.
• W2396425352 cites W2003877353 @default.
• W2396425352 cites W2004838986 @default.
• W2396425352 cites W2005000288 @default.
• W2396425352 cites W2027225184 @default.
• W2396425352 cites W2029741715 @default.
• W2396425352 cites W2030467147 @default.
• W2396425352 cites W2038081872 @default.
• W2396425352 cites W2050181420 @default.
• W2396425352 cites W2054022195 @default.
• W2396425352 cites W2056929310 @default.
• W2396425352 cites W2078979127 @default.
• W2396425352 cites W2080104086 @default.
• W2396425352 cites W2083228007 @default.
• W2396425352 cites W2088509438 @default.
• W2396425352 cites W2090439142 @default.
• W2396425352 cites W2090517304 @default.
• W2396425352 cites W2090848913 @default.
• W2396425352 cites W2094690326 @default.
• W2396425352 cites W2094957230 @default.
• W2396425352 cites W2098332316 @default.
• W2396425352 cites W2114918609 @default.
• W2396425352 cites W2115014715 @default.
• W2396425352 cites W2122248986 @default.
• W2396425352 cites W2127938365 @default.
• W2396425352 cites W2158149590 @default.
• W2396425352 cites W2158682148 @default.
• W2396425352 cites W2160105482 @default.
• W2396425352 cites W2409249536 @default.
• W2396425352 cites W2419578052 @default.
• W2396425352 cites W2578453294 @default.
• W2396425352 cites W2764858847 @default.
• W2396425352 cites W4231111290 @default.
• W2396425352 doi "https://doi.org/10.1177/039463200501800306" @default.
• W2396425352 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16164822" @default.
• W2396425352 hasPublicationYear "2005" @default.
• W2396425352 type Work @default.
• W2396425352 sameAs 2396425352 @default.
• W2396425352 citedByCount "31" @default.
• W2396425352 countsByYear W23964253522012 @default.
• W2396425352 countsByYear W23964253522013 @default.
• W2396425352 countsByYear W23964253522014 @default.
• W2396425352 countsByYear W23964253522015 @default.
• W2396425352 countsByYear W23964253522016 @default.
• W2396425352 countsByYear W23964253522018 @default.
• W2396425352 countsByYear W23964253522019 @default.
• W2396425352 countsByYear W23964253522020 @default.
• W2396425352 countsByYear W23964253522022 @default.
• W2396425352 countsByYear W23964253522023 @default.
• W2396425352 crossrefType "journal-article" @default.
• W2396425352 hasAuthorship W2396425352A5000552772 @default.
• W2396425352 hasAuthorship W2396425352A5022630980 @default.
• W2396425352 hasAuthorship W2396425352A5032110612 @default.
• W2396425352 hasAuthorship W2396425352A5035811881 @default.
• W2396425352 hasAuthorship W2396425352A5051822232 @default.
• W2396425352 hasAuthorship W2396425352A5062084163 @default.
• W2396425352 hasAuthorship W2396425352A5077131670 @default.
• W2396425352 hasConcept C126322002 @default.
• W2396425352 hasConcept C137061746 @default.
• W2396425352 hasConcept C147483822 @default.
• W2396425352 hasConcept C159654299 @default.
• W2396425352 hasConcept C164027704 @default.
• W2396425352 hasConcept C202751555 @default.
• W2396425352 hasConcept C203014093 @default.
• W2396425352 hasConcept C2776914184 @default.
• W2396425352 hasConcept C2776969849 @default.
• W2396425352 hasConcept C2777761686 @default.
• W2396425352 hasConcept C2778690821 @default.
• W2396425352 hasConcept C504460877 @default.
• W2396425352 hasConcept C55493867 @default.
• W2396425352 hasConcept C71924100 @default.
• W2396425352 hasConcept C86803240 @default.
• W2396425352 hasConcept C8891405 @default.
• W2396425352 hasConceptScore W2396425352C126322002 @default.
• W2396425352 hasConceptScore W2396425352C137061746 @default.

• next